1. Home
  2. BMRN vs RCI Comparison

BMRN vs RCI Comparison

Compare BMRN & RCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMRN
  • RCI
  • Stock Information
  • Founded
  • BMRN 1996
  • RCI 1960
  • Country
  • BMRN United States
  • RCI Canada
  • Employees
  • BMRN N/A
  • RCI N/A
  • Industry
  • BMRN Biotechnology: Pharmaceutical Preparations
  • RCI Cable & Other Pay Television Services
  • Sector
  • BMRN Health Care
  • RCI Telecommunications
  • Exchange
  • BMRN Nasdaq
  • RCI Nasdaq
  • Market Cap
  • BMRN 12.1B
  • RCI 13.4B
  • IPO Year
  • BMRN 1999
  • RCI N/A
  • Fundamental
  • Price
  • BMRN $58.07
  • RCI $26.85
  • Analyst Decision
  • BMRN Buy
  • RCI Buy
  • Analyst Count
  • BMRN 22
  • RCI 4
  • Target Price
  • BMRN $93.43
  • RCI $67.00
  • AVG Volume (30 Days)
  • BMRN 2.2M
  • RCI 923.9K
  • Earning Date
  • BMRN 05-01-2025
  • RCI 07-23-2025
  • Dividend Yield
  • BMRN N/A
  • RCI 5.28%
  • EPS Growth
  • BMRN 152.82
  • RCI 196.65
  • EPS
  • BMRN 2.71
  • RCI 2.26
  • Revenue
  • BMRN $2,950,227,000.00
  • RCI $14,386,892,540.00
  • Revenue This Year
  • BMRN $12.27
  • RCI $4.04
  • Revenue Next Year
  • BMRN $10.08
  • RCI $2.26
  • P/E Ratio
  • BMRN $21.47
  • RCI $12.00
  • Revenue Growth
  • BMRN 19.36
  • RCI 1.50
  • 52 Week Low
  • BMRN $52.93
  • RCI $23.18
  • 52 Week High
  • BMRN $94.85
  • RCI $41.84
  • Technical
  • Relative Strength Index (RSI)
  • BMRN 41.32
  • RCI 63.51
  • Support Level
  • BMRN $57.27
  • RCI $25.69
  • Resistance Level
  • BMRN $59.12
  • RCI $26.81
  • Average True Range (ATR)
  • BMRN 1.40
  • RCI 0.44
  • MACD
  • BMRN 0.06
  • RCI 0.16
  • Stochastic Oscillator
  • BMRN 18.34
  • RCI 92.34

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.

About RCI Rogers Communication Inc.

Rogers Communications is the largest wireless service provider in Canada, with its more than 11 million subscribers equating to one third of the total Canadian market. Its wireless business accounted for more than half of total revenue and has increasingly been providing a bigger portion of total company sales over the last several years. Rogers' cable segment, which provides about 35% of total revenue after acquiring Shaw, offers home internet, television, and landline phone service to consumers and businesses. Remaining sales come from Rogers' media unit, which owns and operates various television and radio stations and the Toronto Blue Jays. Rogers' significant exposure to sports also includes ownership stakes in the Toronto Maple Leafs, Raptors, FC, and Argonauts.

Share on Social Networks: